カテゴリ： GlobalData, アメリカ, 企業調査

Puretech Health plc (PRTC)：製薬・医療：M&Aディール及び事業提携情報

◆英語タイトル：Puretech Health plc (PRTC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C11480
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：80
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Puretech Health plc (Puretech), formerly PureTech Ventures LLC, is a biopharmaceutical company that develops medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company develops a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It also develops technology and products for screening, diagnosis, and treatment of neurological disorders such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia. The company offers key experiments and de-risking programs for developing and launching new therapeutics. It markets its products across the US. Puretech is headquartered in Boston, Massachusetts, the US.

Puretech Health plc (PRTC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Puretech Health plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Puretech Health plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Puretech Health plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Puretech Health plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Puretech Health plc, Medical Devices Deals, 2012 to YTD 2018 10
Puretech Health plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Puretech Health plc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Karuna Pharma Raises USD42 Million in Series A Financing 13
resTORbio Raises USD40 Million in Series B Financing 15
resTORbio Raises USD25 Million in Series A Financing 16
Vedanta Biosciences Raises USD50 Million in Venture Financing 17
Gelesis Raises USD31.5 Million in Financing Round 18
Gelesis Raises USD12 Million in Venture Financing 19
Vedanta Biosciences Raises Funds Through Venture Financing 20
DiaTech Oncology Raises US$1.2 Million In Seed Financing 21
Partnerships 22
Akili Interactive Enters into Licensing Agreement with University of California 22
PureTech Health Enters into Co-Development Agreement with Roche 23
Entrega Enters into Agreement with Eli Lilly and Co 24
Vedanta Biosciences Enters into Agreement with Leiden University and Mitchell Cancer 25
Vedanta Biosciences Enters into Agreement with Stanford University School of Medicine 26
Vedanta Biosciences Enters into Agreement with Leiden University Medical Center 27
Vedanta Biosciences Expands Agreement with NYU Langone Medical 28
Vedanta Biosciences Enters into Agreement with NYU Langone Medical Center 29
Knode Enters Into Co-Development Agreement With AstraZeneca 30
Licensing Agreements 31
Vedanta Biosciences Enters into Licensing Agreement with JSR Corp 31
PureTech Health Enters into Licensing Agreement with 3P Biotech 32
Commense Enters into Licensing Agreement with University of British Columbia 33
PureTech Amends Licensing Agreement with Novartis 34
Vedanta Biosciences Enters into Licensing Agreement with Janssen Biotech 35
Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 36
Equity Offering 37
Puretech Health Raises USD100 Million in Private Placement of Shares 37
resTORbio Raises USD97.8 Million in IPO of Shares 38
PureTech Health Spin Off Nybo Therapeutics 39
PureTech Raises USD195 Million in IPO 40
Debt Offering 41
Karuna Pharma Raises USD3.4 Million in Private Placement of Notes 41
Puretech Health plc – Key Competitors 42
Puretech Health plc – Key Employees 43
Puretech Health plc – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Recent Developments 46
Financial Announcements 46
Sep 11, 2018: PureTech Health- Half-Year Report 46
Apr 16, 2018: PureTech Health Announces Annual Results for Year Ended 31 December 2017 49
Aug 30, 2017: PureTech Health: Half-Year Report For Month Ended 30 June 2017 54
Apr 06, 2017: PureTech Health Announces Annual Results for Year Ended 31 December 2016 56
Corporate Communications 60
Oct 17, 2018: PureTech’s Karuna adds Jeff Jonas, MD, to board of directors 60
Jun 05, 2018: PureTech’s Gelesis Appoints Harry Leider, former Walgreens Chief Medical Officer, as Chief Medical Officer and Paul Fonteyne, Chairman and Former CEO of Boehringer Ingelheim USA, to Board of Directors 61
May 02, 2018: PureTech Health Affiliate Sonde Adds Thai Lee to Board of Directors 62
Apr 24, 2018: PureTech Health Appoints Joep Muijrers as Chief Financial Officer 64
Apr 09, 2018: PureTech’s Commense Appoints President and Chief Executive Officer 65
Feb 20, 2018: PureTech Health: Trading Statement 66
Jan 03, 2018: PureTech Health Affiliate resTORbio Adds Lynne Sullivan, Biogen Senior Vice President, to Board of Directors 70
Jun 28, 2017: PureTech Health’s Akili Appoints Former Cubist CEO, Rob Perez, as Executive Chairman 71
Apr 13, 2017: resTORbio Appoints Joan Mannick, M.D., as Chief Medical Officer 73
Mar 02, 2017: PureTech Health Appoints Bharatt Chowrira, Ph.D., J.D., as President and Chief of Business and Strategy 74
Feb 23, 2017: PureTech Health Appoints Atul Pande M.D., Former SVP at GlaxoSmithKline, as Chief Medical Officer 75
Product News 76
Sep 17, 2018: Puretech Health collaborator publishes in nature neuroscience highlighting key role of brain lymphatics in neuroinflammatory conditions like multiple sclerosis 76
May 09, 2017: PureTech Health Announces Initiation of Phase 2b mTORC1 Inhibitors Study in Elderly Patients at Increased Risk of Respiratory Tract Infections 77
04/11/2017: PureTech Health Advances New Programme Targeting Immunosuppressive Gamma Delta T Cells and Related Mechanisms 78
Appendix 80
Methodology 80
About GlobalData 80
Contact Us 80
Disclaimer 80

List of Tables
Puretech Health plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Puretech Health plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Puretech Health plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Puretech Health plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Puretech Health plc, Deals By Therapy Area, 2012 to YTD 2018 9
Puretech Health plc, Medical Devices Deals, 2012 to YTD 2018 10
Puretech Health plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Karuna Pharma Raises USD42 Million in Series A Financing 13
resTORbio Raises USD40 Million in Series B Financing 15
resTORbio Raises USD25 Million in Series A Financing 16
Vedanta Biosciences Raises USD50 Million in Venture Financing 17
Gelesis Raises USD31.5 Million in Financing Round 18
Gelesis Raises USD12 Million in Venture Financing 19
Vedanta Biosciences Raises Funds Through Venture Financing 20
DiaTech Oncology Raises US$1.2 Million In Seed Financing 21
Akili Interactive Enters into Licensing Agreement with University of California 22
PureTech Health Enters into Co-Development Agreement with Roche 23
Entrega Enters into Agreement with Eli Lilly and Co 24
Vedanta Biosciences Enters into Agreement with Leiden University and Mitchell Cancer 25
Vedanta Biosciences Enters into Agreement with Stanford University School of Medicine 26
Vedanta Biosciences Enters into Agreement with Leiden University Medical Center 27
Vedanta Biosciences Expands Agreement with NYU Langone Medical 28
Vedanta Biosciences Enters into Agreement with NYU Langone Medical Center 29
Knode Enters Into Co-Development Agreement With AstraZeneca 30
Vedanta Biosciences Enters into Licensing Agreement with JSR Corp 31
PureTech Health Enters into Licensing Agreement with 3P Biotech 32
Commense Enters into Licensing Agreement with University of British Columbia 33
PureTech Amends Licensing Agreement with Novartis 34
Vedanta Biosciences Enters into Licensing Agreement with Janssen Biotech 35
Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 36
Puretech Health Raises USD100 Million in Private Placement of Shares 37
resTORbio Raises USD97.8 Million in IPO of Shares 38
PureTech Health Spin Off Nybo Therapeutics 39
PureTech Raises USD195 Million in IPO 40
Karuna Pharma Raises USD3.4 Million in Private Placement of Notes 41
Puretech Health plc, Key Competitors 42
Puretech Health plc, Key Employees 43
Puretech Health plc, Other Locations 44
Puretech Health plc, Subsidiaries 44

List of Figures
Puretech Health plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Puretech Health plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Puretech Health plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Puretech Health plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Puretech Health plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Puretech Health plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Puretech Health plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Puretech Health plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Puretech Health plc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Puretech Health plc (PRTC)：製薬・医療：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Sanford Health-医療機器分野：企業M&A・提携分析
    Summary Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center’s medical services include allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding disorders, botox …
  • Linde AG (LIN)-医療機器分野：企業M&A・提携分析
    Summary Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. Linde offers a wide range of compressed and liquefied gases, and chemicals, and offers facili …
  • Vietnam Prosperity Joint-Stock Commercial Bank (VPB)：企業の財務・戦略的SWOT分析
    Vietnam Prosperity Joint-Stock Commercial Bank (VPB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Halcon Resources Corp (HK)：石油・ガス：M&Aディール及び事業提携情報
    Summary Halcon Resources Corp (Halcon) is an independent energy company that acquires, explores, produces, and develops onshore liquids-rich assets. The company owns and operates its oil and gas explorates resources in El Halcon of Eagle Ford shale formation and Bakken and Three Forks formations. It …
  • Nippon Kayaku Co., Ltd.：戦略・SWOT・企業財務分析
    Nippon Kayaku Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Kayaku Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tien Phong Plastic (NTP)：企業の財務・戦略的SWOT分析
    Tien Phong Plastic (NTP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lamellar Biomedical Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Lamellar Biomedical Ltd (Lamellar Biomedical) is a biotechnology company that develops medical products using based on mimetics of extra-alveolar lamellar bodies. The company develops products using its proprietary Lamellasome technology that are mimetics of native extra-alveolar lamellar th …
  • Telenor ASA：企業の戦略・SWOT・財務分析
    Telenor ASA - Strategy, SWOT and Corporate Finance Report Summary Telenor ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Valecha Engineering Ltd：企業の戦略・SWOT・財務分析
    Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Kroger Co：企業のM&A・事業提携・投資動向
    The Kroger Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Kroger Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Banco General SA：企業の戦略・SWOT・財務情報
    Banco General SA - Strategy, SWOT and Corporate Finance Report Summary Banco General SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Wartsila Corporation (WRT1V)：電力：M&Aディール及び事業提携情報
    Summary Wartsila Corporation (Wartsila) is a mechanical or industrial engineering company. It offers smart technologies and complete lifecycle solutions. Through sustainable innovation, total efficiency, and data analytics, the company harnesses the environmental and economic performance of the vess …
  • Kurumoch International Airport：企業の戦略・SWOT・財務分析
    Kurumoch International Airport - Strategy, SWOT and Corporate Finance Report Summary Kurumoch International Airport - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Barbara Ann Karmanos Cancer Institute-製薬・医療分野：企業M&A・提携分析
    Summary Barbara Ann Karmanos Cancer Institute (Karmanos), a subsidiary of McLaren Health Care Corp is a healthcare institute that provides patient care and educational services. The institute offers patient care for the prevention, early detection, treatment and eventual eradication of cancer. Its c …
  • Information Services International-Dentsu Ltd (4812)：企業の財務・戦略的SWOT分析
    Information Services International-Dentsu Ltd (4812) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • TPG Telecom Ltd (TPG)：企業の財務・戦略的SWOT分析
    TPG Telecom Ltd (TPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Guala Closures S.p.A.：企業の戦略・SWOT・財務情報
    Guala Closures S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Guala Closures S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Quest Diagnostics Incorporated：企業のM&A・事業提携・投資動向
    Quest Diagnostics Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Quest Diagnostics Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • FLSmidth & Co. A/S：企業の戦略・SWOT・財務情報
    FLSmidth & Co. A/S - Strategy, SWOT and Corporate Finance Report Summary FLSmidth & Co. A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Enea AB (ENEA)：企業の財務・戦略的SWOT分析
    Summary Enea AB (Enea) is a technology company that provides software solutions. The company offers embedded technologies, testing and validation, certifications, software outsourcing, research and development centers, professional staffing and packaged services. It offers realtime operating system …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆